Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation
- 1 September 2005
- journal article
- clinical trial
- Published by Elsevier in Experimental Neurology
- Vol. 195 (1) , 179-184
- https://doi.org/10.1016/j.expneurol.2005.04.015
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Role of Calcitonin Gene-Related Peptide in the Sensitization of Dorsal Horn Neurons to Mechanical Stimulation After Intradermal Injection of CapsaicinJournal of Neurophysiology, 2004
- Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndromeNeuroscience Letters, 2004
- A New Model of Electrically Evoked Pain and Hyperalgesia in Human SkinAnesthesiology, 2001
- Arthritic calcitonin/α calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivityPain, 2001
- Peptidases: structure, function and modulation of peptide‐mediated effects in the human lungClinical and Experimental Allergy, 1999
- The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptidesBritish Journal of Clinical Pharmacology, 1997
- Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cellsPeptides, 1996
- Tachykinin Peptides, Receptors, and Peptidases in Airway DiseaseExperimental Lung Research, 1995
- Changes in Skin Circulation After Insertion of a Microdialysis Probe Visualized by Laser Doppler Perfusion ImagingJournal of Investigative Dermatology, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976